HeartSciences Inc.
HSCS
$2.05
-$0.02-0.97%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 2.40K | 1.90K | 4.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | 2.40K | 1.90K | 4.40K |
| Cost of Revenue | 0.00 | -- | 1.00K | 800.00 | 1.90K |
| Gross Profit | 0.00 | -- | 1.40K | 1.10K | 2.50K |
| SG&A Expenses | 2.06M | 1.29M | 1.35M | 878.10K | 993.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.54M | 1.93M | 2.08M | 1.88M | 1.92M |
| Operating Income | -2.54M | -1.93M | -2.07M | -1.87M | -1.92M |
| Income Before Tax | -2.75M | -1.99M | -2.35M | -2.06M | -2.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.75M | -1.99M | -2.35M | -2.06M | -2.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.75M | -1.99M | -2.35M | -2.06M | -2.09M |
| EBIT | -2.54M | -1.93M | -2.07M | -1.87M | -1.92M |
| EBITDA | -2.53M | -1.92M | -2.07M | -1.87M | -1.91M |
| EPS Basic | -0.88 | -0.63 | -0.85 | -1.58 | -1.96 |
| Normalized Basic EPS | -0.55 | -0.39 | -0.53 | -0.99 | -1.22 |
| EPS Diluted | -0.88 | -0.63 | -0.85 | -1.58 | -1.96 |
| Normalized Diluted EPS | -0.55 | -0.39 | -0.53 | -0.99 | -1.22 |
| Average Basic Shares Outstanding | 3.14M | 3.16M | 2.78M | 1.30M | 1.07M |
| Average Diluted Shares Outstanding | 3.14M | 3.16M | 2.78M | 1.30M | 1.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |